DrugPatentWatch Database Preview
CAROSPIR Drug Profile
Which patents cover Carospir, and when can generic versions of Carospir launch?
Carospir is a drug marketed by Cmp Dev Llc and is included in one NDA. There is one patent protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in CAROSPIR is spironolactone. There are sixteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the spironolactone profile page.
Summary for CAROSPIR
| International Patents: | 1 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 66 |
| Patent Applications: | 4,176 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CAROSPIR |
| DailyMed Link: | CAROSPIR at DailyMed |
Medical Subject Heading (MeSH) Categories for CAROSPIR
US Patents and Regulatory Information for CAROSPIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for CAROSPIR
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2017075463 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
